Your browser doesn't support javascript.
loading
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.
Erb, Holger H H; Bodenbender, Julia; Handle, Florian; Diehl, Tamara; Donix, Lukas; Tsaur, Igor; Gleave, Martin; Haferkamp, Axel; Huber, Johannes; Fuessel, Susanne; Juengel, Eva; Culig, Zoran; Thomas, Christian.
Affiliation
  • Erb HHH; Department of Urology, Technische Universität Dresden, Dresden, Germany.
  • Bodenbender J; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • Handle F; Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Diehl T; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • Donix L; Department of Urology, Technische Universität Dresden, Dresden, Germany.
  • Tsaur I; National Center for Tumor Diseases (NCT), Dresden, Germany.
  • Gleave M; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • Haferkamp A; The Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Huber J; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • Fuessel S; Department of Urology, Technische Universität Dresden, Dresden, Germany.
  • Juengel E; Department of Urology, Technische Universität Dresden, Dresden, Germany.
  • Culig Z; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • Thomas C; Experimental Urology, Department of Urology, University of Innsbruck, Innsbruck, Austria.
PLoS One ; 15(8): e0237248, 2020.
Article in En | MEDLINE | ID: mdl-32790723
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Prostatic Neoplasms / Drug Resistance, Neoplasm / Tumor Suppressor Proteins / STAT5 Transcription Factor / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2020 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Prostatic Neoplasms / Drug Resistance, Neoplasm / Tumor Suppressor Proteins / STAT5 Transcription Factor / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2020 Document type: Article Affiliation country: Germany Country of publication: United States